81 related articles for article (PubMed ID: 11122244)
1. IL-7 promotes CD95-induced apoptosis in B cells via the IFN-γ/STAT1 pathway.
Sammicheli S; Dang VP; Ruffin N; Pham HT; Lantto R; Vivar N; Chiodi F; Rethi B
PLoS One; 2011; 6(12):e28629. PubMed ID: 22194871
[TBL] [Abstract][Full Text] [Related]
2. Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19.
Leonardi AJ; Proenca RB
Front Immunol; 2020; 11():600405. PubMed ID: 33408715
[TBL] [Abstract][Full Text] [Related]
3. CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L.
Sträter J; Mariani SM; Walczak H; Rücker FG; Leithäuser F; Krammer PH; Möller P
Am J Pathol; 1999 Jan; 154(1):193-201. PubMed ID: 9916933
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of HIV-associated lymphocyte apoptosis: 2010.
Cummins NW; Badley AD
Cell Death Dis; 2010 Nov; 1(11):e99. PubMed ID: 21368875
[TBL] [Abstract][Full Text] [Related]
5. Role of the Fas/FasL pathway in HIV or SIV disease.
Poonia B; Pauza CD; Salvato MS
Retrovirology; 2009 Oct; 6():91. PubMed ID: 19832988
[TBL] [Abstract][Full Text] [Related]
6. Killer B lymphocytes: the evidence and the potential.
Lundy SK
Inflamm Res; 2009 Jul; 58(7):345-57. PubMed ID: 19262989
[TBL] [Abstract][Full Text] [Related]
7. Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.
Eda Y; Murakami T; Ami Y; Nakasone T; Takizawa M; Someya K; Kaizu M; Izumi Y; Yoshino N; Matsushita S; Higuchi H; Matsui H; Shinohara K; Takeuchi H; Koyanagi Y; Yamamoto N; Honda M
J Virol; 2006 Jun; 80(11):5563-70. PubMed ID: 16699037
[TBL] [Abstract][Full Text] [Related]
8. Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.
Eda Y; Takizawa M; Murakami T; Maeda H; Kimachi K; Yonemura H; Koyanagi S; Shiosaki K; Higuchi H; Makizumi K; Nakashima T; Osatomi K; Tokiyoshi S; Matsushita S; Yamamoto N; Honda M
J Virol; 2006 Jun; 80(11):5552-62. PubMed ID: 16699036
[TBL] [Abstract][Full Text] [Related]
9. Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.
Ami Y; Izumi Y; Matsuo K; Someya K; Kanekiyo M; Horibata S; Yoshino N; Sakai K; Shinohara K; Matsumoto S; Yamada T; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Oct; 79(20):12871-9. PubMed ID: 16188989
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
11. Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease.
Yamakami K; Honda M; Takei M; Ami Y; Kitamura N; Nishinarita S; Sawada S; Horie T
J Virol; 2004 Oct; 78(20):10906-10. PubMed ID: 15452210
[TBL] [Abstract][Full Text] [Related]
12. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581
[TBL] [Abstract][Full Text] [Related]
13. Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression.
Arnoult D; Petit F; Lelièvre JD; Lecossier D; Hance A; Monceaux V; Hurtrel B; Ho Tsong Fang R; Ameisen JC; Estaquier J
Cell Death Differ; 2003 Nov; 10(11):1240-52. PubMed ID: 14576776
[TBL] [Abstract][Full Text] [Related]
14. Role of apoptosis induction in both peripheral lymph nodes and thymus in progressive loss of CD4+ cells in SHIV-infected macaques.
Iida T; Ichimura H; Shimada T; Ibuki K; Ui M; Tamaru K; Kuwata T; Yonehara S; Imanishi J; Hayami M
AIDS Res Hum Retroviruses; 2000 Jan; 16(1):9-18. PubMed ID: 10628812
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
[TBL] [Abstract][Full Text] [Related]
16. Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?
Jaworowski A; Crowe SM
Immunol Cell Biol; 1999 Feb; 77(1):90-8. PubMed ID: 10101690
[TBL] [Abstract][Full Text] [Related]
17. How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors.
Cloyd MW; Chen JJ; Adeqboyega P; Wang L
Curr Mol Med; 2001 Nov; 1(5):545-50. PubMed ID: 11899230
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.
Sasaki Y; Ami Y; Nakasone T; Shinohara K; Takahashi E; Ando S; Someya K; Suzaki Y; Honda M
Clin Exp Immunol; 2000 Dec; 122(3):381-9. PubMed ID: 11122244
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
